Dr. Lal PathLabs (BOM:539524) EPS (Basic): ₹31.67 (TTM As of Dec. 2025)


BOM:539524 Dr. Lal PathLabs Ltd BOM:539524
96 GF Score
Price ₹1,659.15
GF Value ₹1,642.65
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Dr. Lal PathLabs EPS (Basic)?

Dr. Lal PathLabs BOM:539524 -0.62% 96 EPS (Basic) is ₹31.67 as of Dec. 2025. GuruFocus rates BOM:539524 with a GF Score™ of 96/100 and a GF Value™ of ₹1,642.65 (Fairly Valued). The stock has 4 warning signs investors should review.

Dr. Lal PathLabs's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was ₹5.42. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹31.67.

Dr. Lal PathLabs's EPS (Diluted) for the three months ended in Dec. 2025 was ₹5.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹31.62.

Dr. Lal PathLabs's EPS without NRI for the three months ended in Dec. 2025 was ₹6.73. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 32.33.

During the past 12 months, Dr. Lal PathLabs's average EPS without NRIGrowth Rate was 29.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 14.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Dr. Lal PathLabs's highest 3-Year average EPS without NRI Growth Rate was 39.60% per year. The lowest was 2.80% per year. And the median was 19.30% per year.

Dr. Lal PathLabs  (BOM:539524) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Dr. Lal PathLabs EPS (Basic) Related Terms

Dr. Lal PathLabs EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Dr. Lal PathLabs's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Lal PathLabs EPS (Basic) Chart

Dr. Lal PathLabs Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.67 20.85 14.41 21.53 29.24

Dr. Lal PathLabs Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.80 9.28 7.94 9.03 5.42
BOM:539524
96GF Score
Dr. Lal PathLabs Ltd BOM:539524
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Lal PathLabs EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Dr. Lal PathLabs's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(4871.38-0)/166.586
=29.24

Dr. Lal PathLabs's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(905-0)/166.974
=5.42

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹31.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹31.67 mean?
Dr. Lal PathLabs (BOM:539524) has a EPS (Basic) of ₹31.67 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Dr. Lal PathLabs and its competitors.
Is Dr. Lal PathLabs' EPS (Basic) too high?
Dr. Lal PathLabs' current EPS (Basic) is ₹31.67. Overall, Dr. Lal PathLabs has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Lal PathLabs' EPS (Basic) compare to TMO and DHR?
Dr. Lal PathLabs' EPS (Basic) of ₹31.67 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Dr. Lal PathLabs and its competitors. Dr. Lal PathLabs's current EPS (Basic) is ₹31.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Lal PathLabs stock overvalued right now?
Based on GuruFocus' analysis, Dr. Lal PathLabs (BOM:539524) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,642.65, compared to a current price of ₹1,659.15 — trading 1% above its estimated fair value. The current EPS (Basic) is ₹31.67. Dr. Lal PathLabs' overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Dr. Lal PathLabs (BOM:539524), the current EPS (Basic) is ₹31.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Lal PathLabs (BOM:539524) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued. The current stock price of ₹1,659.15 is trading 1% above its estimated GF Value™ of ₹1,642.65. GuruFocus considers Dr. Lal PathLabs to be Fairly Valued.

Key valuation signals for BOM:539524:

  • EPS (Basic): ₹31.67
  • GF Value™: ₹1,642.65 vs. price of ₹1,659.15 (1% above fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the BOM:539524 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Lal PathLabs Business Description

Other Exchanges LALPATHLAB:India
Address 12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
96GF Score

Get the complete analysis for BOM:539524

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,659.15
Price
₹1,642.65
GF Value